Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemalkumar B Mehta

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Medical Care|October 18, 2024
Hospital-Level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort StudyG Caleb Alexander, Brian T Garibaldi, Huijun An, et al.
American Journal of Epidemiology|October 9, 2025
Identifying observable medication use time in administrative databases: A tutorial using nursing home residentsDaniel A Harris, Adam D'Amico, Hemalkumar B Mehta, et al.
JNCI Cancer Spectrum|December 3, 2020
Proximity to Oil Refineries and Risk of Cancer: A Population-Based AnalysisStephen B Williams, Yong Shan, Usama Jazzar, et al.
Annals of Internal Medicine|August 16, 2021
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort StudyHemalkumar B Mehta, Huijun An, Kathleen M Andersen, et al.
The Lancet. Rheumatology|November 22, 2021
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort CollaborativeKathleen M Andersen, Benjamin A Bates, Emaan S Rashidi, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2022
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort studyKathleen M Andersen, Corey S Joseph, Hemalkumar B Mehta, et al.
Frontiers in Oncology|April 1, 2024
Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort studyShiming Zhang, Lin-Na Chou, Michael D Swartz, et al.
JAMA Surgery|June 6, 2019
Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder CancerStephen B Williams, Yong Shan, Mohamed D Ray-Zack, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Plos Medicine|January 17, 2025
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Medical Care|October 18, 2024
Hospital-Level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort StudyG Caleb Alexander, Brian T Garibaldi, Huijun An, et al.
American Journal of Epidemiology|October 9, 2025
Identifying observable medication use time in administrative databases: A tutorial using nursing home residentsDaniel A Harris, Adam D'Amico, Hemalkumar B Mehta, et al.
JNCI Cancer Spectrum|December 3, 2020
Proximity to Oil Refineries and Risk of Cancer: A Population-Based AnalysisStephen B Williams, Yong Shan, Usama Jazzar, et al.
Annals of Internal Medicine|August 16, 2021
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort StudyHemalkumar B Mehta, Huijun An, Kathleen M Andersen, et al.
The Lancet. Rheumatology|November 22, 2021
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort CollaborativeKathleen M Andersen, Benjamin A Bates, Emaan S Rashidi, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2022
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort studyKathleen M Andersen, Corey S Joseph, Hemalkumar B Mehta, et al.
Frontiers in Oncology|April 1, 2024
Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort studyShiming Zhang, Lin-Na Chou, Michael D Swartz, et al.
JAMA Surgery|June 6, 2019
Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder CancerStephen B Williams, Yong Shan, Mohamed D Ray-Zack, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Plos Medicine|January 17, 2025
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Pageof 10